Search results
Takeda Pharmaceuticals layoff plan follows $1.87 million in Massachusetts tax incentives
FOX 25 Boston· 5 days agoLess than one year after being awarded a nearly $2 million tax incentive for its commitment to...
Takeda's TAK-861 shows promise in narcolepsy trial By Investing.com
Investing.com· 11 hours agoOSAKA, Japan & CAMBRIDGE, Mass. - Takeda Pharmaceutical Company (NYSE:TAK) Limited (TSE:...
Takeda Pharmaceutical Co ADR (TAK) gets rating Upgrade from BofA Securities – Knox Daily
Knox Daily· 21 hours agoTakeda Pharmaceutical Co ADR’s filing revealed that its 10% Owner TAKEDA PHARMACEUTICAL CO LTD unloaded Company’s ...
Tell us: Are you a current or former Takeda employee? We want to hear about it. - The Boston Globe
The Boston Globe· 6 days agoDrug-making giant Takeda Pharmaceutical announced last week that it would lay off more than 640...
Blackstone Is Considering the Sale of Alinamin Pharmaceutical, Sources Say
Bloomberg via Yahoo Finance· 19 hours ago(Bloomberg) -- Blackstone Inc. is considering a sale of Japanese consumer health-care firm Alinamin...
Blackstone Weighs Sale Of Japanese Pharma Firm Alinamin: Report - Blackstone (NYSE:BX)
Benzinga· 13 hours agoBlackstone reportedly considers sale of Japanese consumer healthcare firm Alinamin Pharmaceutical...
Over 600 employees facing layoffs by Massachusetts’ largest biotech company
The Republican· 5 days agoOver 600 employees of Takeda Pharmaceuticals USA, Inc., are facing layoffs beginning in July. Takeda...
The state's largest life science employer will cut over 600 jobs - Boston Business Journal
The Business Journals· 7 days agoJust a few weeks after announcing it planned to kick off a “significant, multiyear efficiency...
Takeda is planning hundreds of layoffs in Massachusetts
CBS News· 5 days agoTakeda is planning to lay off more than 600 people in Massachusetts. The news comes one year after...
...Opinion for Recombinant ADAMTS13 (rADAMTS13) in Congenital Thrombotic Thrombocytopenic Purpura...
Benzinga· 4 days agoTakeda ((TAK) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval, under exceptional circumstances, ...